Beyond the Diagnosis: Navigating Life with GI Disorders
From debunking social media myths to providing peer support, learn how the GI Society helps patients manage the "new normal" of digestive health.
What’s Driving 105,000 Canadians A Year To Seek Care Abroad?
105,529 Canadians sought care abroad last year. From urology to eye surgery, we break down the procedures driving the exodus and how to stay safe.
6 Million Canadians Living with Heart Disease: New 2026 Report
Heart & Stroke report reveals 90% of Canadians have at least one risk factor for heart disease. Learn about the new data on hypertension, diabetes, and vaping.
Canada’s Growing Gut Health Crisis
Canada has some of the world's highest rates of IBD. Facing 2026, the CDHF discusses specialist wait times, the impact of chronic GI symptoms and tools Canadians can use to help themselves.
The $37 Billion Blind Spot: Why Canada Needs to Close the Women’s Health Gap
Canadian women spend 24% more time in poor health than men. Discover why this $37B gap exists and how to advocate for the care you deserve.
Kidney Breakthrough: Health Canada Authorizes First-of-its-Kind Treatment for Lupus Nephritis
Health Canada authorizes Gazyva for lupus nephritis. Discover how this twice-yearly treatment improves kidney response and prevents failure.
New Study Warns of Rapid Weight Regain When Quitting Weight Loss Drugs
New research shows stopping weight loss medication leads to rapid regain, with many returning to their original weight in less than two years.
Gen Z Health Crisis: Mental Health and Chronic Disease Claims Soar in Canada
A new Sun Life report reveals Gen Z health claims for mental health and chronic disease are rising 3x faster than any other generation in Canada.
Does HRT Increase Dementia Risk? New 1M Woman Study
A study of 1M women finds HRT doesn't increase dementia risk. We dive into the findings and why women are still more likely to face Alzheimer's.
Health Canada Authorizes Nemluvio® for Eczema and Prurigo Nodularis
Health Canada authorized Nemluvio® (nemolizumab), a first-in-class biologic for eczema and prurigo nodularis. Learn about costs and coverage.
Health Canada Authorizes First GLP-1 Pill to Reduce Heart Attack and Stroke Risk
Health Canada authorizes RYBELSUS® as the first oral GLP-1 to reduce heart attack and stroke risk in adults with type 2 diabetes.
Confronting the Silence Around Dementia: Why Not Knowing Isn’t a Strategy
New data reveals Canadians are avoiding dementia diagnoses and how facing the facts early can preserve your independence and health.